Payment by PayID or bank transfer.
A Certificate of Analysis is not currently linked for this product.
Published research is separate from the batch test results for this vial.
Browse the research libraryAdamax is a synthetic nootropic research peptide - a structurally modified Semax/P21 analogue studied in neuroplasticity and BDNF-pathway research. Supplied as a 10mg lyophilised vial for laboratory research use only.
Listed Purity
99.84%
Method
HPLC
Certificate
Not published$16.00 / mg
In stock, ships from Sydney
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Adamax is a synthetic nootropic research peptide - a structurally modified Semax/P21 analogue studied in neuroplasticity and BDNF-pathway research. Supplied as a 10mg lyophilised vial for laboratory research use only.
Adamax (acetylated, amidated, adamantane-modified) pairs the Semax heptapeptide backbone (Met-Glu-His-Phe-Pro-Gly-Pro) with an adamantane group - the P21-type modification studied for greater metabolic stability and blood-brain-barrier penetration. In preclinical research it is examined alongside Semax and Selank in BDNF/NGF expression, synaptic plasticity, and stress-response signalling. Adamax has no human clinical trials and reported effects are anecdotal; it is supplied strictly as a laboratory research compound, not for human consumption. >=99% purity, shipped from Australia.
